Proprietary and unique multiple unit processing technologies

ADD utilizes proprietary and contemporary processing technologies for multiparticulate preparations with proven functionality and outstanding performance in development, manufacturing of clinical trial material and commercial quantities.

Our techniques are mainly based on fluid bed technologies for direct pelletization, granulation and coating.
These innovative technologies along with our expertise offer unique solutions for the desired physical and biopharmaceutical profiles.
ADD's proven track record on commercialized products clearly indicates our ability to solve difficult drug delivery and product life cycle management challenges.

 

CPS™ is a fluidized bed direct pelletization system with
controlled particle movement.
• Drug concentrations 
   from 1 to 90 %
• Adjustable release rate
• Wide range of particle sizes 
   from 100 to 1400 μm
• Narrow particle size distribution,
   typically +/- 50 μm

ProCell™ allows a continuous spray granulation process.
• Drug loading up to 100 %
• Particle size range adjustable
   from 50 to 1500 μm
• Co-processing of excipients
   and drug substances

MicroPx™ is a continuous fluidized
bed direct pelletization technology.
• High drug loading (> 90 %)
   and high yield
• Particle range
   from 50 to 500 μm
• Narrow particle size distribution,
   typically +/- 25 μm
• Spherical, dust free and smooth
   surface with low attrition
• Ideal core pellets for taste
   masked products